Reviva Pharmaceuticals Holdings (RVPH) EPS (Basic) (2018 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted EPS (Basic) of -$0.46 for Q1 2026, up 51.99% sequentially from -$0.95 in Q4 2025, and up 82.79% YoY from -$0.25 in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) EPS (Basic) (2018 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported EPS (Basic) for 9 years, with the latest figure at -$0.46 in Q1 2026.
- Quarterly EPS (Basic) rose 82.79% year-over-year to -$0.46 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.38 (down 721.91% YoY) and the FY2025 annual result came in at -$5.5, down 12756.3% from the prior year.
- EPS (Basic) grew to -$0.46 in Q1 2026 per RVPH's latest filing, from -$0.95 in the prior quarter.
- Over five years, EPS (Basic) peaked at $14.23 in Q4 2024 and troughed at -$12.32 in Q4 2022.
- A 5-year average of -$4.24 and a median of -$4.97 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 287.85% in 2022, then soared 282.01% in 2024.
- Over 5 years, EPS (Basic) stood at -$12.32 in 2022, then surged by 36.54% to -$7.82 in 2023, then surged by 282.01% to $14.23 in 2024, then sank by 106.66% to -$0.95 in 2025, then soared by 51.99% to -$0.46 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.46, -$0.95, and -$1.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 0.18 |
| 10 | Reviva Pharmaceuticals Holdings | 6.34 Mn | 6.34 Mn | - | -0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.35 |
| Mar 31, 2026 | -0.46 |
| Dec 31, 2025 | -0.95 |
| Sep 30, 2025 | -1.10 |
| Jun 30, 2025 | -2.43 |
| Mar 31, 2025 | -2.64 |
| Dec 31, 2024 | 14.23 |
| Sep 30, 2024 | -4.95 |
| Jun 30, 2024 | -5.14 |
| Mar 31, 2024 | -4.97 |
| Dec 31, 2023 | -7.82 |
| Sep 30, 2023 | -9.44 |
| Jun 30, 2023 | -10.44 |
| Mar 31, 2023 | -6.28 |
| Dec 31, 2022 | -12.32 |
| Sep 30, 2022 | -3.65 |
| Jun 30, 2022 | -5.78 |
| Mar 31, 2022 | -7.98 |
| Dec 13, 2021 | -4.98 |
| Sep 30, 2021 | -2.47 |